Skmo Here is how you can create your Instagram end-of-year recap reel
Denis Villeneuves first Dune managed to become a hit in 2021, even as it came out during the pandemic and with a simultaneous streaming date on HBO Max. After WB and Legendary greenlit Dune: Part Two for 2023 to the delig taza stanley ht of many , ant stanley thermobecher icipation for it has been through the roof, even when it was delayed stanley flasche to 2024 due to the strikes. Now its here, and its not wrong to say that folks are fairly high on Dune: Part Twos supply. Ahead of release, Part Two racked up largely positive reactions from critics, with some calling it a worthy adaptation to Frank Herberts novel and a sci-fi classic in the making. Like the first film, praise has been heaped onto Villeneuves direction, visuals, and the cast, to the point that some are already wondering if it has any Oscars chances. However that shakes out, Part Twos definitely the first blockbuster of the year, and itll be sticking with folks for a while. Given the early praise鈥攁nd if hits it big at the box office鈥擵illeneuve will likely get to make that adaptation of Dune Messiah hes been openly interested in doing to close out this hopeful trilogy. Being such a big movie, we want to know any of your thoughts on Dune: Part Two. Did you love it, hate it How does it compare to Part One and David Lynchs 1984 film聽for you, and how far do you think this franchise will go Let us know what you think聽in the comments down below. Want more io9 news Check out when to expect the latest Marvel, Star Wars, and Star Trek releases, whats next for th Mqzm Penguin Adds a Do-Not-Scrape-for-AI Page to Its Books
SOPA Images/LightRocket鈥擥ettyBy Alice ParkMarch 11, 2021 6:55 PM ESTNovavax reported on March 11 that its COVID-19 stanley cup vaccine is 96% efficacious in reducing mild, moderate or severe disease. The Maryland-based company joins the ha stanley termosas ndful of manufacturers that have reported encouraging data on a COVID-19 vaccine; three, Pfizer-BioNTech, Moderna and Johnson Johnsonrsquo Janssen Pharmaceuticals, have already received emergency use authorization for their shots from the U.S. Food and Drug Administration.Novavax revealed the final results of its Phase 3 human trials of NVX-CoV2373 in a press release; the findings have not been submitted for peer-review in a scientific journal yet. The company reported that overall, its vaccine was 96% efficacious in protecting people from mild, moderate or severe COVID-19 disease if they were infected with the original SARS-CoV-2 virus. The vaccine was slightly less efficacious, at 86%, in protecting against disease if people were infected with the B.1.1.7 strain of the virus, which is becoming dominant in the U.K., where the study was conducted. That gives the vaccine an overall efficacy of 89.7% against both the original and U.K. variants. By comparison, Pfizer-BioNTech vaccine is 95% efficacious against COVID-19 disease, Moderna is 94%, and Johnson Johns stanley tumbler on is 66%.In an ongoing, Phase 2B study of the vaccine in South Africa, where a more worrisome variant is increasingly responsible for a growing share of new in